Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Gross Margin Growth (3y) (2012 - 2026)

Analysis

Resmed (RMD) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 264.00
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 104.00
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn -89.00
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 459.00
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 8.00
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn -316.00
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 73.00
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 382.00
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 393.00
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 113.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 382.00
Mar 31, 2026 694.00
Dec 31, 2025 568.00
Sep 30, 2025 455.00
Jun 30, 2025 372.00
Mar 31, 2025 251.00
Dec 31, 2024 224.00
Sep 30, 2024 257.00
Jun 30, 2024 249.00
Mar 31, 2024 -30.00
Dec 31, 2023 -217.00
Sep 30, 2023 -390.00
Jun 30, 2023 -331.00
Mar 31, 2023 -313.00
Dec 31, 2022 -194.00
Sep 30, 2022 -59.00
Jun 30, 2022 4.00
Mar 31, 2022 -71.00
Dec 31, 2021 -117.00
Sep 30, 2021 -231.00